📰 Sutter Capital News
Sutter Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sutter Capital. Real-time updates on events, politics, business and more.
June 4, 2024
Glaukos Co. (NYSE:GKOS – Get Free Report) Director Gilbert H. Kliman sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $112.00, for a total transaction of $560,000.00. Following the completion of the sale, the director now owns 30,620 shares in the […]
May 27, 2024
Analysts at StockNews.com started coverage on shares of HomeStreet (NASDAQ:HMST – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the financial services provider’s stock. Several other research firms have also commented on HMST. Wedbush boosted their price target on shares of HomeStreet from $15.00 to $16.00 […]
May 6, 2024
Glaukos (NYSE:GKOS – Free Report) had its price target upped by JPMorgan Chase & Co. from $108.00 to $110.00 in a research report report published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical instruments supplier’s stock. Several other research firms also recently commented on GKOS. Citigroup boosted […]
May 2, 2024
Coombe Bender & Co LLC bought a new stake in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,584 shares of the biopharmaceutical company’s stock, valued at approximately $334,000. Other institutional investors and hedge funds have […]
April 30, 2024
Van ECK Associates Corp lifted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 33.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,984,150 shares of the biopharmaceutical company’s stock after acquiring an additional 3,265,276 shares during the period. Van ECK Associates Corp owned […]
April 28, 2024
Consolidated Planning Corp decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 36.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,782 shares of the biopharmaceutical company’s stock after selling 5,645 shares during the quarter. Consolidated Planning Corp’s holdings in Pfizer […]
April 28, 2024
Intellectus Partners LLC increased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 83,435 shares of the biopharmaceutical company’s stock after buying an additional 8,352 shares during the quarter. Intellectus Partners LLC’s holdings in Pfizer were worth […]
April 24, 2024
Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $102.60 and last traded at $101.81, with a volume of 32614 shares trading hands. The stock had previously closed at $101.10. Wall Street Analysts Forecast Growth A number of […]
April 24, 2024
Glaukos Co. (NYSE:GKOS – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $102.60 and last traded at $101.81, with a volume of 32614 shares traded. The stock had previously closed at $101.10. Analyst Ratings Changes A number of analysts have recently commented […]
April 24, 2024
Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $102.60 and last traded at $101.81, with a volume of 32614 shares trading hands. The stock had previously closed at $101.10. Wall Street Analysts Forecast Growth A number of […]